Sigyn Therapeutics, Inc. (OTCMKTS:SIGY – Get Free Report)’s stock price dropped 5.4% on Monday . The company traded as low as $2.64 and last traded at $2.65. Approximately 262 shares were traded during trading, an increase of 523,900% from the average daily volume of 0 shares. The stock had previously closed at $2.80.
Sigyn Therapeutics Trading Down 5.4%
The company has a market cap of $4.27 million, a price-to-earnings ratio of -0.58 and a beta of -1.07. The company’s 50 day moving average price is $2.77 and its 200 day moving average price is $3.40.
Sigyn Therapeutics (OTCMKTS:SIGY – Get Free Report) last released its earnings results on Tuesday, May 20th. The company reported ($0.42) EPS for the quarter.
About Sigyn Therapeutics
Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.
Further Reading
- Five stocks we like better than Sigyn Therapeutics
- Using the MarketBeat Stock Split Calculator
- Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4
- How to Invest in Biotech Stocks
- Why Datadog Is the AI Infrastructure Firm to Watch Out For
- Most active stocks: Dollar volume vs share volume
- 4 Stocks Every AI ETF Is Buying—And They’re Not What You Think
Receive News & Ratings for Sigyn Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigyn Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
